![A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses – topic of research paper in Clinical medicine. Download scholarly article A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses – topic of research paper in Clinical medicine. Download scholarly article](https://cyberleninka.org/viewer_images/1481894/f/1.png)
A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses – topic of research paper in Clinical medicine. Download scholarly article
![Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090825811009735-fx2.jpg)
Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect
![Diagnostics | Free Full-Text | Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy Diagnostics | Free Full-Text | Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy](https://pub.mdpi-res.com/diagnostics/diagnostics-13-00452/article_deploy/html/images/diagnostics-13-00452-g001.png?1675751411)
Diagnostics | Free Full-Text | Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy
![Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2487ea26-1e5f-4b40-9ecd-fddbb803589d/ntbl003.jpg)
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library
![PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f50dc44db73d02a0fdaecab49c845d96479f6e8f/3-Table1-1.png)
PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar
![ROC plot and AUC for CA125 and HE4 for patients with epithelial ovarian... | Download Scientific Diagram ROC plot and AUC for CA125 and HE4 for patients with epithelial ovarian... | Download Scientific Diagram](https://www.researchgate.net/publication/235365939/figure/fig1/AS:202511693684737@1425293958793/ROC-plot-and-AUC-for-CA125-and-HE4-for-patients-with-epithelial-ovarian-cancer-and-benign.png)
ROC plot and AUC for CA125 and HE4 for patients with epithelial ovarian... | Download Scientific Diagram
![PDF) Evaluation of tumor marker HE4 assay on the Elecsys 2010 analyzer | Journal of Health Sciences - Academia.edu PDF) Evaluation of tumor marker HE4 assay on the Elecsys 2010 analyzer | Journal of Health Sciences - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/38286313/mini_magick20190225-2481-1u6ohw6.png?1551147769)
PDF) Evaluation of tumor marker HE4 assay on the Elecsys 2010 analyzer | Journal of Health Sciences - Academia.edu
Simultaneous Detection of Ovarian Cancer-Concerned HE4 and CA125 Markers Based on Cu Single-Atom-Triggered CdS QDs and Eu MOF@Isoluminol ECL | Analytical Chemistry
![Table I from The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer | Semantic Scholar Table I from The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ad5e941b87910036df87050d122d3db985bbadce/2-TableI-1.png)
Table I from The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer | Semantic Scholar
![Frontiers | Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer Frontiers | Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer](https://www.frontiersin.org/files/Articles/364491/fonc-08-00124-HTML/image_m/fonc-08-00124-g001.jpg)
Frontiers | Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer
![Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science](http://www.eurekaselect.com/images/graphical-abstract/cdt/21/10/006.jpg)
Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science
![A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Clinics A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Clinics](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//18075932/0000006700000005/v1_202212011555/S1807593222018178/v1_202212011555/en/main.assets/gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNfuNpdT3pEXC7tmqfbE1Y0Z1p9+vAlVDCDNpqpxHzzp8Z0ILrOhT7YePrkmPFgJXhRefw4ABU3JKFsav571eCDEBUhjI79Bed2vwyg+06u15e5p0zEc7NR8pKOODemQ8Jl7shbpnR5Z7fS6msjciMc9exfReX6xEt3CpsUcLrQq2+COvxzN0YvO0v9diCVzdtXH5DjBo0uguSf7DejoHnqvOJgN9DgkVeQr5ZRPIsThWOr2uAw3C2JxlJ7ad8KbJ5A=)
A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Clinics
![Comparative analysis of both markers, HE4 and CA125, as prognostic factors. | Download Scientific Diagram Comparative analysis of both markers, HE4 and CA125, as prognostic factors. | Download Scientific Diagram](https://www.researchgate.net/publication/350528081/figure/tbl2/AS:1017251813658626@1619543140940/Comparative-analysis-of-both-markers-HE4-and-CA125-as-prognostic-factors.png)
Comparative analysis of both markers, HE4 and CA125, as prognostic factors. | Download Scientific Diagram
![Electrochemical immunomagnetic assay as biosensing strategy for determination of ovarian cancer antigen HE4 in human serum - ScienceDirect Electrochemical immunomagnetic assay as biosensing strategy for determination of ovarian cancer antigen HE4 in human serum - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0039914020302824-fx1.jpg)
Electrochemical immunomagnetic assay as biosensing strategy for determination of ovarian cancer antigen HE4 in human serum - ScienceDirect
![Prognostic and predictive value of combined HE-4 and CA-125 biomarkers during chemotherapy in patients with epithelial ovarian cancer - Enrico Potenza, Giulia Parpinel, Maria E. Laudani, Chiara Macchi, Luca Fuso, Paolo Zola, Prognostic and predictive value of combined HE-4 and CA-125 biomarkers during chemotherapy in patients with epithelial ovarian cancer - Enrico Potenza, Giulia Parpinel, Maria E. Laudani, Chiara Macchi, Luca Fuso, Paolo Zola,](https://journals.sagepub.com/cms/10.1177/1724600820955195/asset/images/large/10.1177_1724600820955195-fig2.jpeg)
Prognostic and predictive value of combined HE-4 and CA-125 biomarkers during chemotherapy in patients with epithelial ovarian cancer - Enrico Potenza, Giulia Parpinel, Maria E. Laudani, Chiara Macchi, Luca Fuso, Paolo Zola,
![PDF) HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Jose Miguel Escudero - Academia.edu PDF) HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Jose Miguel Escudero - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/49394150/mini_magick20190131-26445-njjm3w.png?1548982026)